Metformin, as a first-line antidiabetic medication for type 2 diabetes(T2D), appears to ameliorate the pathogenesis of PCOS, restore ovarian function, improve the inflammatory state and enhance metabolic status, particularly insulin sensitivity by activating the AMP-activated protein kinase (AMPK) pathway [4]. Here, INS is linked to type 2 diabetes mellitus.